KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $40.9 million.

  • Vertex Pharmaceuticals' Other Working Capital Changes rose 29476.19% to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $310.0 million, marking a year-over-year decrease of 3634.5%. This contributed to the annual value of $200.3 million for FY2024, which is 6329.49% down from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Other Working Capital Changes of $40.9 million as of Q3 2025, which was up 29476.19% from $76.4 million recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Other Working Capital Changes ranged from a high of $451.3 million in Q4 2023 and a low of -$99.2 million during Q1 2024
  • Moreover, its 5-year median value for Other Working Capital Changes was $28.1 million (2025), whereas its average is $68.9 million.
  • Examining YoY changes over the last 5 years, Vertex Pharmaceuticals' Other Working Capital Changes showed a top increase of 188930.82% in 2022 and a maximum decrease of 60827.07% in 2022.
  • Vertex Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$15.9 million in 2021, then soared by 1889.31% to $284.5 million in 2022, then surged by 58.63% to $451.3 million in 2023, then plummeted by 63.53% to $164.6 million in 2024, then tumbled by 75.15% to $40.9 million in 2025.
  • Its Other Working Capital Changes stands at $40.9 million for Q3 2025, versus $76.4 million for Q2 2025 and $28.1 million for Q1 2025.